0001562180-19-005622.txt : 20191121
0001562180-19-005622.hdr.sgml : 20191121
20191121063131
ACCESSION NUMBER: 0001562180-19-005622
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191120
FILED AS OF DATE: 20191121
DATE AS OF CHANGE: 20191121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ADAMS ADRIAN
CENTRAL INDEX KEY: 0001248144
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 191235672
MAIL ADDRESS:
STREET 1: C/O AUXILIUM PHARMACEUTICALS, INC.
STREET 2: 640 LEE ROAD
CITY: CHESTERBROOK
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-11-20
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001248144
ADAMS ADRIAN
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST ST.
CAMBRIDGE
MA
02142
true
false
false
false
Common Stock
2019-11-20
4
P
false
50000.00
3.41
A
63700.00
D
The purchase reported in this Form 4 was made on the open market.
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.37 to $3.44, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
/s/ Nicole R. Hadas, attorney-in-fact for Adrian Adams
2019-11-21